Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery

Clinical trial NCT04369703 · COMPLETED

Trial details

NCT number: NCT04369703
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Sellar and Suprasellar Masses Pituitary Tumor

Start date: 2020-01-28
Primary completion: 2022-04-29
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.